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Abstract — Chemometrics is the field of science covering the development and application of mathematical 
and statistical methods to identify important chemical information. It is indispensable in the evaluation of 
experimental results and suitable for exploration of large data sets. Within the Trans2Care project we intend 
to apply chemometrics methods in several areas related to the problems explored by the Project partners. 
In particular we shall investigate transmembrane protein transport mechanism with data-driven modelling 
approach and also applying biomolecular simulations. We’ll combine our theoretical approach with 
experimental data provided by the Project partners, which will contribute to a better exploration of the available 
information in biomolecular systems studied, in the research of neurodegenerative diseases, in cardiovascular 
and pathohistological research. It will also intensify the collaboration, mobility of researchers and exchange of 
knowledge between partners. 
Index Terms — chemometrics, data mining, predictive modelling, transmembrane proteins
_____________________________________________________________________ 
1 BACKGROUND
Overweight and obesity are common conditions affecting health in all age and gender group and can 
lead to development of metabolic syndrome (MetS), a cluster of the medical disorders that increase risk 
of developing Type 2 Diabetes Mellitus and cardiovascular diseases (CVD). Obesity is associated with 
inflammation and accompanied by high oxidative status. Indeed, oxidative stress has been associated 
with adiposity, insulin resistance and MetS, suggesting that oxidative stress could be an early event 
in the pathology of these chronic diseases. Overweight can be considered as a pre-disease state that 
can compromise the antioxidant defence system on a long-term basis. From this perspective, low 
serum concentrations of endogenous antioxidants can be an early sign of disease-prone conditions 
in apparently healthy asymptomatic middle-aged individuals. Bilirubin, for example, the end product 
of heme metabolism, is an endogenous antioxidant with anti-inflammatory properties and it has 
been shown that high bilirubin serum concentrations are associated with increased total antioxidant 
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capacity, and confer protection against oxidative stress-induced diseases. Indeed, subjects with 
moderately elevated levels of serum bilirubin, such as those with Gilbert Syndrome, are at decreased 
risk of CVD.
Serum bilirubin is therefore gaining interest in preventive medicine, because higher serum bilirubin 
levels are correlated with the reduced cardiovascular disease risk. Thus, measuring serum bilirubin 
levels might become a predictive biomarker for indicating asymptomatic individuals at increased risk 
of developing MetS and other chronic oxidative stress induced pathologies. 
2 OBJECTIVES
The objective of our study was therefore to evaluate the correlations between total and direct serum 
bilirubin levels and MetS components and inflammatory markers in asymptomatic healthy overweight 
individuals.
3 APPROACH & METHODS
General approach
1. Blood collection. 2. Serum preparation. 3. Measuring of total and direct serum bilirubin levels. 4. 
Perform correlation analysis.
Methods
This is a cross-sectional study involving 96 healthy adults aged 25-45 (64 women and 32 men). All 
participants underwent standard anthropometrical measurements of body composition, aerobic and 
anaerobic capabilities assessment, dietary intake evaluation, and fasting serological measurements of 
direct and total bilirubin, fasting glucose, insulin, total cholesterol, LDL cholesterol, HDL cholesterol, 
triacylglycerols, and C-reactive protein. Participants were divided in overweight and normal weight 
groups.  Linear correlation analyses were used to examine the association between serum bilirubin 
levels with all metabolic syndrome risk factor changes.
4 RESULTS
Serum bilirubin levels were lower in healthy overweight individuals of both sexes (Figure 1). 
 
Figure 1: Serum bilirubin levels in normal weight and overweight group for male and female subjects. A direct 
bilirubin levels. B total bilirubin levels.
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Moreover, serum bilirubin levels were negatively associated with abdominal obesity, insulin resistance, 
fasting glucose, fasting insulin, fasting triacylglycerols, fasting total cholesterol, LDL cholesterol, and 
C-reactive protein but positively associated with aerobic body capabilities (Figure 2).
Figure 2: Correlations between total serum bilirubin levels and some of the metabolic syndrome components, CRP, 
and physical fitness.
212
Furthermore, the mean values for direct and total bilirubin values decreased with increasing numbers of 
metabolic syndrome components, in both men and women, as shown in Table 1.
Table 1: Relationship of serum bilirubin levels according to the number of metabolic syndrome components.
n (%) Bilirubin-direct Bilirubin-total
Zero components of MetS
     Male 7 (22 %) 2.96 (0.36) 16.13 (2.10)
     Female 24 (37 %) 2.49 (0.22) 14.00 (1.17)
One component of MetS
     Male 9 (28 %) 2.76 (0.38) 15.92 (2.35)
     Female 26 (41 %) 2.16 (0.26) 13.16 (1.51)
Two components of MetS
     Male 9 (28 %) 2.21 (0.17) 13.22 (1.10)
     Female 10 (16 %) 1.69 (0.27) 11.21 (1.22)
Three and more 
components of MetS
     Male 7 (22 %) 1.91 (0.23) 12.31 (1.30)
     Female 4 (6 %) 1.55 (0.44) 10.20 (1.38)
5 POTENTIAL NEW PRODUCTS & SERVICES
Product: Analysis of serum bilirubin levels can be used as early biomarkers for indicating asymptomatic 
individuals at increased risk of developing MetS and other chronic oxidative stress induced pathologies. 
Service: Analysis of serum bilirubin levels as an early biomarkers for indicating asymptomatic individuals 
at increased risk of developing MetS and other chronic oxidative stress induced pathologies can be 
utilized as service for customers such as medical institutions, scientific institutions, SMEs, as well as to 
general public, which enables highly-motivated individuals to check their blood antioxidant status.
6 CURRENT COLLABORATIONS
6.1 With other researchers 
The University of Primorska, Faculty of Health Sciences (PP12, Trans2Care), Universities of Nova Gorica 
(PP3, Trans2Care), and Trieste (LP, Trans2Care) form a research consortium on bilirubin in biomedical 
research.
7 CONTACT OR COLLABORATIONS NEEDED
Future collaboration with clinical laboratories is needed.
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8 COMMUNICATION TOOLS
This study has been presented to the biomedical community at the University of Primorska (http://
www.trans2care.eu/NewsData.aspx?IdNews=68&ViewType=Old&IdType=390), 
University of Ferrara (http://www.trans2care.eu/NewsData.aspx?IdNews=81&ViewType=Old&IdTy
pe=390), 
Chemistry towards Biology on 10-13 September 2013 (Trieste, Italy), and
10th Congress of Slovenian Biochemical Society 2013 on 15-18 September 2013 (Ljubljana, Slovenia).
9 FUNDS NEEDED
9.1 For basic research (investigation of biological mechanisms): 25.000 €  
9.2 For applied research (solutions for real-world problems): 50.000 €
9.2 For pilot & demonstrator activities (to develop a prototype): 90.000 €
10 CONCLUSION
Analysis of serum bilirubin levels have the potential to be used in the preventive medicine as early 
biomarker for indicating asymptomatic individuals at increased risk of developing MetS and other 
chronic oxidative stress pathologies.
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